GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

PHASE2CompletedINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
DyslipidaemiasDyslipidaemia
Interventions
DRUG

GW501516 oral tablets

Trial Locations (64)

1200

GSK Investigational Site, Brussels

2317

GSK Investigational Site, Hamar

2900

GSK Investigational Site, Hellerup

4000

GSK Investigational Site, Liège

5231

GSK Investigational Site, Paradis

10117

GSK Investigational Site, Berlin

10559

GSK Investigational Site, Berlin

10614

GSK Investigational Site, Tallinn

10787

GSK Investigational Site, Berlin

11312

GSK Investigational Site, Tallinn

12524

GSK Investigational Site, Berlin

13055

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

13158

GSK Investigational Site, Berlin

13347

GSK Investigational Site, Berlin

13419

GSK Investigational Site, Tallinn

14052

GSK Investigational Site, Caen

17140

GSK Investigational Site, Lagord

20246

GSK Investigational Site, Hamburg

21423

GSK Investigational Site, Winsen/Lohe

22525

GSK Investigational Site, Hamburg

31300

GSK Investigational Site, Toulouse

33200

GSK Investigational Site, Tampere

38154

GSK Investigational Site, Koenigslutter

38610

GSK Investigational Site, Gières

39120

GSK Investigational Site, Magdeburg

39326

GSK Investigational Site, Wolmirstedt

41749

GSK Investigational Site, Viersen

47574

GSK Investigational Site, Goch

51069

GSK Investigational Site, Cologne

55116

GSK Investigational Site, Mainz

59269

GSK Investigational Site, Beckum

63571

GSK Investigational Site, Gelnhausen

70210

GSK Investigational Site, Kuopio

83527

GSK Investigational Site, Haag

85635

GSK Investigational Site, Höhenkirchen-Siegertsbrunn

94000

GSK Investigational Site, Créteil

86000 cedex

GSK Investigational Site, Poitiers

04103

GSK Investigational Site, Leipzig

04107

GSK Investigational Site, Leipzig

04229

GSK Investigational Site, Leipzig

04315

GSK Investigational Site, Leipzig

01762

GSK Investigational Site, Schmiedeberg

LT-50009

GSK Investigational Site, Kaunas

LT-08314

GSK Investigational Site, Vilnius

LT-08661

GSK Investigational Site, Vilnius

1311 RL

GSK Investigational Site, Almere Stad

5751 XJ

GSK Investigational Site, Deurne

4872 LA

GSK Investigational Site, Etten-Leur

7442 LS

GSK Investigational Site, Nijverdal

2281 AK

GSK Investigational Site, Rijswijk

2371 RB

GSK Investigational Site, Roelofarendsveen

3045 PM

GSK Investigational Site, Rotterdam

6027 RN

GSK Investigational Site, Soerendonk

2582 LJ

GSK Investigational Site, The Hague

N-1357

GSK Investigational Site, Bekkestua

N-1601

GSK Investigational Site, Fredrikstad

0160

GSK Investigational Site, Oslo

0176

GSK Investigational Site, Oslo

0319

GSK Investigational Site, Oslo

N-1920

GSK Investigational Site, Soerumsand

N-4011

GSK Investigational Site, Stavanger

3000-075

GSK Investigational Site, Coimbra

SE-205 02

GSK Investigational Site, Malmo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY